Global Allergic Rhinitis Market, By Type (Seasonal, Perennial, Occupational Rhinitis), Treatment (Immunotherapy, Antihistamines, Decongestants, Vertebral Fusion, Corticosteroids, Others), Route of Administration (Oral, Parenteral, Intranasal), Form (Solid, Liquid), Test (Skin Test, IgE RAST Test, Complete Blood Count), Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Online Stores), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028.
The allergic rhinitis market is expected to witness market growth at a rate of 3.65% in the forecast period of 2021 to 2028. Data Bridge Market Research report on allergic rhinitis market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth. The rise in the prevalence of respiratory disorders is escalating the growth of allergic rhinitis market.
Allergic rhinitis, also called hay fever refers to an allergic reaction caused by increased sensitivity to allergens in the surrounding environment of the patients. The individual suffers from runny or stuffy nose, constant sneezing, swelling & redness around the eyes along with watery eyes. Increased amount of pollen in the environment has been seen as one of the most common cause of this allergic reaction.
The surge in demand for effective and potent drugs among consumers across the globe acts as one of the major factors driving the growth of allergic rhinitis market. The increase in the prevalence of various forms of allergic rhinitis including seasonal allergic rhinitis, perennial allergic rhinitis, and occupational allergic rhinitis among population and rise in government initiatives to promote awareness regarding allergic rhinitis, accelerate the market growth. The rise in the levels of strategies and collaborative practices undertaken by various manufacturers to focus on better delivery of treatment and increase in demand for easy to administer drugs and methods, further influence the market. Additionally, growth in awareness, surge in healthcare expenditure and rise in pollution positively affect the allergic rhinitis market. Furthermore, development of new products, and the presence of strong pipeline portfolio extends profitable opportunity to the market players in the forecast period of 2021 to 2028.
On the other hand, availability and increased adoption of alternative treatment options are expected to obstruct the market growth. High competition from generic drugs for the disease as major patents are on the verge of expiration is projected to challenge the allergic rhinitis market in the forecast period of 2021-2028.
This allergic rhinitis market provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on allergic rhinitis market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Allergic Rhinitis Market Scope and Market Size
The allergic rhinitis market is segmented on the basis of type, treatment, route of administration, form, test and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of type, the allergic rhinitis market is segmented into seasonal, perennial, and occupational rhinitis.
- On the basis of treatment, the allergic rhinitis market is segmented into immunotherapy, antihistamines, decongestants, vertebral fusion, corticosteroids and others.
- On the basis of route of administration, the allergic rhinitis market is segmented into oral, parenteral, and intranasal.
- On the basis of form, the allergic rhinitis market is segmented into solid and liquid.
- On the basis of test, the allergic rhinitis market is segmented into skin test, IgE RAST Test, and complete blood count.
- On the basis of distribution channel, the allergic rhinitis market is segmented into hospital pharmacies, retail pharmacies and online stores.
Global Allergic Rhinitis Market Country Level Analysis
The allergic rhinitis market is analyzed and market size insights and trends are provided by country, type, treatment, route of administration, form, test and distribution channel as referenced above.
The countries covered in the global allergic rhinitis market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the allergic rhinitis market because of the presence of major market players and availability of advanced medications for the treatment within the region. Asia-Pacific is expected to witness the fastest growth during the forecast period of 2021-2028 because of the continuous developments in developing countries such as India and China.
The country section of the allergic rhinitis market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The allergic rhinitis market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for allergic rhinitis market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on allergic rhinitis market. The data is available for historic period 2010-2019.
Competitive Landscape and Allergic Rhinitis Market Share Analysis
The allergic rhinitis market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to allergic rhinitis market.
The major players covered in the allergic rhinitis market report are Merck KGaA, GSK group of companies, Sanofi, Cigna, Himalaya Wellness, Janssen Global Services, LLC, FAES Farma SA, Hisamitsu Pharmaceutical Co., Inc., Glenmark Pharmaceuticals, Olainfarm, Boehringer Ingelheim International GmbH, Covis Pharma, Teva Pharmaceutical Industries Ltd., Sandoz International GmbH, ALK and Meda among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.